Literature DB >> 17599312

Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users.

Maureen Miller1, Christian Cespedes, Meera Bhat, Peter Vavagiakis, Robert S Klein, Franklin D Lowy.   

Abstract

A longitudinal study of 282 community-based drug users was conducted from February 1999 through September 2000. Both the incidence (15.0 cases per 100 person-years at risk; 95% confidence interval, 10.2-20.7 cases per 100 person-years at risk) and persistence of Staphylococcus aureus carriage were increased among human immunodeficiency virus (HIV)-seropositive individuals.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17599312     DOI： 10.1086/519429

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  17 in total

1.  Prevalence and risk factors for MRSA nasal colonization among persons experiencing homelessness in Boston, MA.

Authors:  Jessica H Leibler; Casey León; Lena J P Cardoso; Jennifer C Morris; Nancy S Miller; Daniel D Nguyen; Jessie M Gaeta
Journal:  J Med Microbiol       Date:  2017-08       Impact factor: 2.472

Review 2.  A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.

Authors:  James A McKinnell; Loren G Miller; Samantha J Eells; Eric Cui; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-19       Impact factor: 3.254

3.  The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.

Authors:  Rachel J Gordon; Nancy Chez; Haomiao Jia; Barbara Zeller; Magda Sobieszczyk; Caitlin Brennan; Katherine B Hisert; Mei-Ho Lee; Peter Vavagiakis; Franklin D Lowy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Prevalence of Staphylococcus aureus Nasal Carriage in Human Immunodeficiency Virus-Infected and Uninfected Children in Botswana: Prevalence and Risk Factors.

Authors:  Michael J A Reid; Rebecca S B Fischer; Naledi Mannathoko; Charles Muthoga; Erin McHugh; Heather Essigmann; Eric L Brown; Andrew P Steenhoff
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

6.  Prevalence, persistence, and microbiology of Staphylococcus aureus nasal carriage among hemodialysis outpatients at a major New York Hospital.

Authors:  Elizabeth L Alexander; Daniel J Morgan; Sandra Kesh; Scott A Weisenberg; Janice M Zaleskas; Anna Kaltsas; James M Chevalier; Jeffrey Silberzweig; Yolanda Barrón; Jose R Mediavilla; Barry N Kreiswirth; Kyu Y Rhee
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02-18       Impact factor: 2.803

7.  Prevalence and behavioural risk factors of Staphylococcus aureus nasal colonization in community-based injection drug users.

Authors:  N S Leung; P Padgett; D A Robinson; E L Brown
Journal:  Epidemiol Infect       Date:  2014-12-01       Impact factor: 4.434

8.  Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children.

Authors:  N H T M Dukers-Muijrers; E Stobberingh; P Beisser; R C H Boesten; P Jacobs; C J P A Hoebe
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

9.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

10.  Staphylococcus aureus in the community: colonization versus infection.

Authors:  Maureen Miller; Heather A Cook; E Yoko Furuya; Meera Bhat; Mei-Ho Lee; Peter Vavagiakis; Paul Visintainer; Glenny Vasquez; Elaine Larson; Franklin D Lowy
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.